QA: Relmada Therapeutics INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001553643_2016_Relmada_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001553643, Relmada Therapeutics INC

  xvar xval
0 AssetsCurrent 23,967,871
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 23,911
3 remainder_Assets 400,825
4 LiabilitiesCurrent 15,582,673
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,226,883
9 ResearchAndDevelopmentExpense 7,872,397
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -3,704,316
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 24,392,607
1 Liabilities 15,582,673
2 Expenses 17,099,280
3 Revenues 0
4 StockholdersEquity 8,809,934
5 NetIncome -20,803,596
6 ComprehensiveNetIncome -20,803,596
7 BaseVar 30,389,438
8 EconomicCapitalRatiobeforeLimitedLiability -0.0799
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution